Storys aus Germany

18.09.2014 – 17:14
Merck Healthcare Germany
Merck Strengthens Executive Board
Darmstadt, Germany (ots/PRNewswire) - - Stefan Oschmann appointed Deputy CEO and Vice Chairman of the Executive Board - Belen Garijo appointed new member of the Executive Board - Changes effective from January 1, 2015 Merck today announced that the Board of Partners has promoted Stefan Oschmann (57) to the position of Deputy CEO and Vice Chairman of the Executive Board. Concurrently, Belen Garijo (54) was appointed to the Executive Board to take over leadership for the ...
mehr
12.09.2014 – 16:09
Merck Healthcare Germany
Merck Discontinues Clinical Development Program of Tecemotide as a Monotherapy in Stage III Non-Small Cell Lung Cancer
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK-based media Merck announced today that its biopharmaceutical division Merck Serono will discontinue the clinical development program of its investigational MUC1 antigen-specific cancer immunotherapy tecemotide (also known as L-BLP25) as a monotherapy in Stage ...
mehr
09.09.2014 – 10:01
GfK Custom Research
GfK's 2015 Sales Forecasts for Technology Products
Nuremberg, Germany (ots/PRNewswire) - GfK has today announced the availability of its 2015 sales forecasts for all major technology product categories worldwide. GfK's forecasts, called Target Setter, are built from weekly point of sale (POS) data, gathered from GfK's global retail sales tracking in over 70 countries - the largest and most comprehensive dataset available. This makes GfK's forecasts stand out for ...
mehr
03.09.2014 – 12:06
Merck Healthcare
Merck Announces Detailed 26-Week Results from Phase IIIb Study with Kuvan in Children with PKU Below 4 Years of Age
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK based media - Detailed 26-week results of SPARK study presented at SSIEM Annual Symposium - Phenylalanine tolerance significantly increased in children with PKU below 4 years of age, previously shown to be responsive to Kuvan and treated with Kuvan plus a ...
mehr
29.07.2014 – 08:31
Merck Healthcare
Merck Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma
Darmstadt, Germany (ots/PRNewswire) - - First patient begins treatment in an international Phase II study investigating the efficacy and safety of MSB0010718C in patients with metastatic Merkel cell carcinoma (mMCC) - mMCC is a rare and aggressive skin cancer lacking effective treatments - MSB0010718C is also ...
mehr
10.06.2014 – 13:53
Merck Healthcare
Merck Serono Announces FDA Clearance for Auxogyn's Early Embryo Viability Assessment (Eeva®) System
Darmstadt, Germany (ots/PRNewswire) - - FDA clearance validates Eeva System, which enables in-vitro fertilization (IVF) clinicians to offer the proprietary Eeva Test and further demonstrates commitment by Merck Serono and Auxogyn to bring innovative technologies to the IVF community - Eeva Test first-of-a-kind ...
mehr

01.06.2014 – 01:31
Merck Healthcare Germany
Merck to Collaborate with Sysmex Inostics on a Blood-Based RAS Biomarker Test
Darmstadt, Germany (ots/PRNewswire) - - Development and commercialization agreement on blood-based RAS biomarker mutation status test for (metastatic) colorectal cancer (mCRC) - This non-invasive, fast and easy-to-perform diagnostic test is expected to provide a real-time reflection of a patient's RAS mutation status to help guide clinical decision making in mCRC Merck ...
mehr
29.05.2014 – 08:31
Merck Healthcare
Merck Serono to Release New Pipeline Data at ASCO 2014 from Early-Stage Investigational Compounds in Difficult-to-Treat Cancers
Darmstadt, Germany (ots/PRNewswire) - ASCO abstract #: Anti-PD-L1: 3064; c-Met: 2521, TPS4151, TPS8121; tecemotide: TPS3658, TPS7608; TH-302: 8534, 2029; further pipeline: 3551, TPS9107, 5030, 2050, e13552 - Robust pipeline reflects commitment to innovation in oncology and immuno-oncology - Data from nine Merck ...
mehr
26.05.2014 – 08:31
Merck Healthcare
Merck Serono Supports 6th International Thyroid Awareness Week
Darmstadt, Germany (ots/PRNewswire) - - For the 6th time in a row Merck Serono takes part in the International Thyroid Awareness Week with focus on HIGH FIVE - Five reasons to be aware of thyroid disease: Thyroid cancer, autoimmunity, infertility, anxiety/depression, and iodine deficiency Merck Serono, the biopharmaceutical division of Merck, together with Thyroid ...
mehr
15.05.2014 – 10:53
Merck Healthcare Germany
Merck Announces New Retrospective Analysis Shows Significant Clinical Benefit in Overall Survival for Metastatic Colorectal Cancer Patients with RAS Wild-Type Tumors Receiving Erbitux plus FOLFIRI
Darmstadt, Germany (ots/PRNewswire) - ASCO Abstract Number: 3506 - In a retrospective analysis of the Phase III CRYSTAL* study, which assessed RAS tumor status, significant clinical benefit was observed in mCRC patients with RAS wild-type tumors receiving Erbitux plus FOLFIRI, compared with FOLFIRI alone - No ...
mehr
24.04.2014 – 08:31
Merck Healthcare Germany
Merck Announces Positive Outcome of IIIb Study for Kuvan
Darmstadt, Germany (ots/PRNewswire) - - Primary endpoint met in SPARK study: significant increase in phenylalanine tolerance demonstrated after 26 weeks of the study in children less than 4 years of age with phenylketonuria and responsive to Kuvan treated with Kuvan plus a phenylalanine-restricted diet, versus diet alone - SPARK study was conducted as a post-authorization measure and results will be submitted to EMA this ...
mehr
10.04.2014 – 22:01
Qiagen N.V.
QIAGEN Adds Promising New Biomarker to Pipeline of Personalized Healthcare Assays to Improve Diagnosis of Blood Disorders
Hilden, Germany And Vienna (ots/PRNewswire) - - Reliable diagnostic tools under development for mutations of calreticulin (CALR) are expected to benefit patients with blood disorders known as myeloproliferative neoplasms - QIAGEN acquired exclusive worldwide license for CALR biomarker from CeMM Vienna, whose ...
mehr

07.04.2014 – 08:21
Merck Healthcare
Merck Serono Announces Initiation of Phase III START2 Study with Tecemotide in Stage III Non-Small Cell Lung Cancer
Darmstadt, Germany (ots/PRNewswire) - - First patient dosed in tecemotide Phase III trial; study recruiting across 250 sites in over 20 countries - START2 builds upon the data from the START* trial and explores the potential of tecemotide in patients with Stage III NSCLC who have demonstrated stable disease or ...
mehr
02.04.2014 – 13:01
Daiichi Sankyo Europe GmbH
Daiichi Sankyo extends the PREFER in AF patient registry to provide additional insights into the long-term management of patients with atrial fibrillation
Munich, Germany (ots/PRNewswire) - For European Media Only, Not for UK Media Atrial fibrillation (AF) is the most common heart rhythm disorder[1] resulting in a five-fold increased risk of stroke compared with the general population[2] Daiichi Sankyo today announced its commitment to extend the PREvention oF ...
mehr
31.03.2014 – 07:21
Merck Healthcare
New Global Initiative Aims to Improve Patient Outcomes in Metastatic Colorectal Cancer
Darmstadt, Germany (ots/PRNewswire) - - The multidisciplinary Oncology Partnership and Education Network (OPEN) aims to improve patient outcomes in oncology, with initial focus on metastatic colorectal cancer (mCRC) - OPEN aims to raise public awareness and understanding of the importance of biomarker testing in mCRC Merck Serono, the biopharmaceutical division of ...
mehr
27.03.2014 – 08:22
Merck Healthcare Germany
Merck Announces Initiation of Phase III Fertility Study with Pergoveris in Poor Ovarian Response Patients
Darmstadt, Germany (ots/PRNewswire) - - The ESPART* Phase III clinical study focuses on patients that respond poorly to attempts at ovarian stimulation - Study aims to recruit 946 patients across 17 European countries Merck, the global pharmaceutical and chemical company, today announced the enrollment of the first ...
mehr
19.03.2014 – 13:10
Linde Healthcare
The REALfund: Linde Supporting Innovative Ideas in Respiratory Care
Pullach, Germany (ots/PRNewswire) - As a globally leading healthcare company, Linde Healthcare is dedicated to research and innovative developments. The REALfund supports purposeful solutions within respiratory medicine that benefit patients and caregivers alike. For further information and to apply, visit the REALfund website at ...
mehr
08.01.2014 – 10:03
UBM Live
Jewellery & Gem Fair Europe Meets the Industry's Demands
Freiburg, Germany (ots/PRNewswire) - 99 percent of floor space is already booked Leading representatives of the international jewellery and gemstone industry has expressed the need for an appropriate and commercially focused jewellery sourcing platform in Europe. With the Jewellery & Gem Fair Europe, UBM has responded by providing such a platform, at the cross roads of the industry's most important hubs, such as Antwerp, ...
mehr

23.12.2013 – 10:28
Merck Healthcare
European Commission Approves Update of Erbitux Metastatic Colorectal Cancer Labeling to Patients With RAS Wild-Type Tumors
Darmstadt, Germany (ots/PRNewswire) - - The European Commission's approval is based on the CHMP positive opinion - Label update comes in response to new biomarker data obtained from the OPUS study Merck Serono, the biopharmaceutical division of Merck, today announced that the European Commission has approved the ...
mehr
18.12.2013 – 16:02
Merck Healthcare
Merck Enters Into License Agreement With the Spanish National Cancer Research Centre (CNIO)
Darmstadt, Germany (ots/PRNewswire) - - New agreement aims to translate CNIO research into new potential treatment options for cancer patients - License agreement encompasses two series of ATR inhibitors and a screening platform Merck Serono, the biopharmaceutical division of Merck, today announced that a license ...
mehr
16.12.2013 – 14:05
Grünenthal GmbH
Grünenthal and AcelRx enter into partnership for EU commercialization of ZALVISO®
Aachen, Germany / Redwood City (California), USA (ots) - Grünenthal Group today announced that the company entered into a commercial partnership with AcelRx Pharmaceuticals, Inc. for ZALVISO, a patient-controlled analgesia device for self- administration of sufentanil nanotablets by patients following surgery. The agreement covers the countries of the European Union, ...
mehr
09.12.2013 – 11:17
Merck Healthcare
Merck Serono Announces New Publication of Results of the Phase III START Trial Investigating Tecemotide in Non-Small Cell Lung Cancer in The Lancet Oncology
Darmstadt, Germany (ots/PRNewswire) - - Publication offers detailed results of START, including an exploratory analysis of the clinically meaningful survival prolongation with tecemotide maintenance therapy in a predefined subgroup of patients treated with concurrent chemoradiotherapy - As previously announced Merck ...
mehr
04.12.2013 – 10:02
UBM Live
Food Ingredients Europe Closes With Record Attendance and Takes the Industry to 2020 by Delivering Leading Insight on the Latest Innovations and Trends
Frankfurt Am Main, Germany (ots/PRNewswire) - Food ingredients Europe proved once again it's the world's leading food industry event. In Frankfurt from the 19-21 November the doors welcomed close to 25,000 attendees. And an outstanding 80% of visitors confirmed that they control the purse strings of some the world's ...
mehr
25.11.2013 – 12:30
UBM Live
Roquette's Microalgae High Lipid Algal Flour Wins Most Innovative Food Ingredient at the 2013 Fi Europe Excellence Awards
Frankfurt Am Main, Germany (ots/PRNewswire) - Roquette's innovative new Microalgae High Lipid Algal Flour has been recognised as the most innovative food ingredient of 2013. Successfully reducing fat and replacing eggs while providing sustainability, health, functionality and cost benefits to producers and consumers ...
mehr

22.11.2013 – 18:15
Merck Healthcare
Merck Serono Announces CHMP Positive Opinion to Update Erbitux Metastatic Colorectal Cancer Labeling to Patients with RAS Wild-type Tumors
Darmstadt, Germany (ots/PRNewswire) - - CHMP recommendation comes in response to new biomarker data obtained from the OPUS study Merck Serono, the biopharmaceutical division of Merck, today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a ...
mehr
20.11.2013 – 15:12
Philips Healthcare
Transforming Healthcare: Philips Unveils Solutions at MEDICA
Düsseldorf, Germany (ots/PRNewswire) - New healthcare solutions developed with users and patients help improve the recovery process and treatment options for patients while supporting medical staff in their work Healthcare is constantly changing. The best way to deal with this change is for all parties in the sector to join forces. Philips is putting this principle into action under the banner "Transforming healthcare, ...
mehr
13.11.2013 – 08:32
Merck Healthcare
Merck Enters into Further Global Co-Development and Commercialization Agreement for PARP Inhibitor with Chinese R&D Company BeiGene
Darmstadt, Germany (ots/PRNewswire) - - New agreement marks the second collaboration between Merck and BeiGene Merck Serono, the biopharmaceutical division of Merck, today announced that a global licensing, co-development, and commercialization agreement for BeiGene-290 has been signed with BeiGene Co., Ltd., a ...
mehr
24.10.2013 – 14:13
UBM Live
CPhI Pharma Awards Showcase Industry Drivers
Frankfurt, Germany (ots/PRNewswire) - API Corporation, E-Pharma Trento and Camurus- the 2013 winners The CPhI Pharma Awards 2013 winners were announced live at the awards ceremony- day one at CPhI Worldwide [http://www.cphi.com ]. Honouring outstanding developments from some key industry players, the awards highlighted ever-advancing market innovations, fundamental to driving growth throughout global pharma. (Logo: ...
mehr
23.10.2013 – 10:02
UBM Live
CPhI Annual Expert Industry Report (Part ii): Live from CPhI Worldwide
Frankfurt, Germany (ots/PRNewswire) - CPhI expert industry panel members highlight future implications for pharma in final part of CPhI industry report Industry to encounter drug shortages and threat of adulterated products, with pharma shifting focus to orphan drug development, low cost products and continuous processing Report's expert highlights Girish Malhotra, ...
mehr
22.10.2013 – 10:02
UBM Live
CPhI Annual Expert Industry Report (Part II): Live from CPhI Worldwide
Frankfurt, Germany (ots/PRNewswire) - CPhI Expert Industry Panel Members Comment on Future Contingencies for Pharma in Part II of CPhI Industry Report Pharma to change business model to include increased academic partnerships, CMO development work, more niched products, industry-wide QbD and regulation of suppliers Report's expert highlights Sam Venugopal, Director, ...
mehr

Vorherige45678910111213Nächste